Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

NASDAQ:INZY

Overview | Financials
Company Name Inozyme Pharma, Inc.
Symbol INZY
Currency USD
Price 5
Market Cap 309,277,500
Dividend Yield 0%
52-week-range 2.689 - 7.795
Industry Biotechnology
Sector Healthcare
CEO Dr. Douglas A. Treco Ph.D.
Website https://www.inozyme.com

An error occurred while fetching data.

About Inozyme Pharma, Inc.

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for

Related Stocks

OptiNose, Inc. logo

OptiNose, Inc.

OPTN

1.24 USD

Omeros Corporation logo

Omeros Corporation

OMER

3.77 USD

Longeveron Inc. logo

Longeveron Inc.

LGVN

1.81 USD

Biomea Fusion, Inc. logo

Biomea Fusion, Inc.

BMEA

4.63 USD

Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.

CODX

1.37 USD

Chimerix, Inc. logo

Chimerix, Inc.

CMRX

0.933 USD

Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

MIST

1.42 USD

Financials

Numbers are in millions USD

Numbers are in millions USD